We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » J&J’s Antibiotic Drug Levaquin Gains a Dozen Generic Competitors
J&J’s Antibiotic Drug Levaquin Gains a Dozen Generic Competitors
June 28, 2011
The FDA announced the first approvals of generic versions of Johnson & Johnson’s (J&J) blockbuster antibiotic Levaquin, as the product loses its exclusivity. Levaquin (levofloxacin) garnered $1.4 billion in sales for J&J last year. Generic Line
